Last reviewed · How we verify

NCT04780451

Omega-3 Supplementation Combined With Endurance Training Improve Running Economy in Recreational Runners.

Completed Phase 3 Last updated 3 March 2021
What this trial tests

Phase 3 trial testing Omega-3 supplementation in recreational runners in Effect of Omega-3 Supplementation on Exercise Performance and Muscle Tissue Functions in 40 participants. Completed in 2 March 2021.

Timeline
16 September 2020
Primary endpoint
20 December 2020
2 March 2021

Quick facts

Lead sponsorGdansk University of Physical Education and Sport
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposebasic science
Enrollment40
Start date16 September 2020
Primary completion20 December 2020
Estimated completion2 March 2021
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Gdansk University of Physical Education and Sport

Who can join

Adults 29 to 42, male only, with Effect of Omega-3 Supplementation on Exercise Performance and Muscle Tissue Functions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Recreational male runners participated in 12 weeks training and omega-3 supplementation programme. Before starting and at the end of the 12-week cycle, the runners performed an increasing intensity treadmill test where oxygen uptake and VO2 peak were assessed.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of 12 Wk of Omega-3 Fatty Acid Supplementation in Long-Distance Runners.
    Tomczyk M, Jost Z, Chroboczek M, Urbański R, et al · · 2023 · cited 16× · PMID 36161864 · DOI 10.1249/mss.0000000000003038

Verify or expand the search:

Other Gdansk University of Physical Education and Sport trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04780451.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing